Overview

Denali Therapeutics Inc. is a biotechnology company focused on the discovery and development of therapeutics for neurodegenerative diseases. With a robust pipeline, Denali aims to address the unmet medical needs of patients suffering from Alzheimer's, Parkinson's, ALS, and other neurodegenerative disorders.

Therapeutic areas

Neurodegenerative DiseasesAlzheimer's DiseaseParkinson's DiseaseAmyotrophic Lateral Sclerosis (ALS)

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Denali Therapeutics Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Denali Therapeutics Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.